← back to search

Andrés Matoso

Brown University · US
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research focused on Bladder cancer and TSC1, with related work in Tuberous sclerosis, Prostate cancer, Renal cell carcinoma. Notable publications include 'Defining clinically significant prostate cancer on the basis of pathological findings', 'Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials', and 'Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes'.
h-index
citations
1,437
works
25
NIH funding
primary concept
email

Recent publications

Assessment and classification of sex cord‐stromal tumours of the testis: recommendations from the testicular sex cord‐stromal tumour (<scp>TESST</scp>) group, an Expert Panel of the Genitourinary Pathology Society (<scp>GUPS</scp>) and International Society of Urological Pathology (<scp>ISUP</scp>)
Histopathology 2025cited by 11position: middledoi
Observer Variation in the Diagnosis of Testicular Sex Cord-Stromal Tumors by a Genitourinary Pathology Society and International Society of Urological Pathology Panel: Paving the Way for a New Classification
Modern Pathology 2025cited by 8position: middledoi
YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulation
Journal of Clinical Investigation 2024cited by 34position: middledoi
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
European Urology 2023cited by 53position: middledoi
<scp>GPNMB</scp> expression identifies <scp>TSC1</scp>/2/<scp>mTOR</scp>‐associated and <scp>MiT</scp> family translocation‐driven renal neoplasms
The Journal of Pathology 2022cited by 99position: middledoi
Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma
Histopathology 2022cited by 16position: middledoi
Myoid gonadal stromal tumours are characterised by recurrent chromosome‐level copy number gains: molecular assessment of a multi‐institutional series
Histopathology 2022cited by 13position: middledoi
Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes
Applied immunohistochemistry & molecular morphology 2021cited by 150position: lastdoi
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers
Advances in Anatomic Pathology 2021cited by 55position: middledoi
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia
Advances in Anatomic Pathology 2021cited by 44position: middledoi
<scp>BCG</scp> invokes superior <scp>STING</scp>‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer
The Journal of Pathology 2021cited by 18position: middledoi
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
European Urology 2020cited by 67position: middledoi
Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Clinical Cancer Research 2019cited by 161position: middledoi
Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study
Human Pathology 2019cited by 39position: middledoi
Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva
Human Pathology 2019cited by 24position: middledoi
Defining clinically significant prostate cancer on the basis of pathological findings
Histopathology 2018cited by 191position: firstdoi
Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations
The American Journal of Surgical Pathology 2018cited by 143position: middledoi
A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression
Neoplasia 2018cited by 60position: middledoi
Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis
The American Journal of Surgical Pathology 2018cited by 38position: middledoi
Re‐evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients
Histopathology 2017cited by 130position: middledoi
INSL3 Expression in Leydig Cell Hyperplasia and Leydig Cell Tumors
Applied immunohistochemistry & molecular morphology 2017cited by 21position: lastdoi
The Significance of Lymphovascular Invasion of the Spermatic Cord in the Absence of Cord Soft Tissue Invasion
Archives of Pathology & Laboratory Medicine 2017cited by 19position: middledoi
Do Nonseminomatous Germ Cell Tumors of the Testis With Lymphovascular Invasion of the Spermatic Cord Merit Staging as pT3?
The American Journal of Surgical Pathology 2017cited by 16position: middledoi
Pathologic and clinical characteristics of early onset renal cell carcinoma
Human Pathology 2017cited by 14position: middledoi
Prostate-specific Antigen Mass Density—A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution
Urology 2016cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jonathan I. Epstein · Bladder Cancer Advocacy Network7 papers (2016–2022)George J. Netto · University of Pennsylvania7 papers (2017–2022)Kara A. Lombardo · Brown University6 papers (2017–2021)Thomas M. Ulbright · Indiana University School of Medicine5 papers (2017–2025)Max Kates · Johns Hopkins Medicine5 papers (2016–2021)Pedram Argani · Johns Hopkins University5 papers (2017–2022)Muhammad T. Idrees · Indiana University School of Medicine5 papers (2017–2025)Jennifer Gordetsky · University of Alabama at Birmingham5 papers (2017–2019)David J. McConkey · Johns Hopkins University5 papers (2019–2024)Trinity J. Bivalacqua · Twitter (United States)5 papers (2018–2021)Woonyoung Choi · Johns Hopkins Medicine4 papers (2019–2024)Chia‐Sui Kao · Cleveland Clinic4 papers (2017–2025)Soroush Rais‐Bahrami · University of Colorado Cancer Center4 papers (2017–2019)Maurizio Colecchia · Vita-Salute San Raffaele University3 papers (2022–2025)Lynette M. Sholl · Harvard University3 papers (2022–2025)Fiona Maclean · Royal North Shore Hospital3 papers (2022–2025)Sean R. Williamson · Indiana University School of Medicine3 papers (2022–2025)Andrés Acosta · University of Illinois Chicago3 papers (2022–2025)Lauren E. Schwartz · University of Pennsylvania3 papers (2017–2019)Květoslava Michalová · Jackson Memorial Hospital3 papers (2022–2025)